When analyzing the overall impact of IL-22 in HCC development, three independent studies implied a pathogenic role of this cytokine since high serum levels of IL-22 were associated with a worse prognosis and shorter disease-free survival [122, 125, 126]. The gene discussed is IL22; the disease is hepatocellular carcinoma.